Table 3.
HRs for the risk of total and specific cancer in diabetes group
| HR (95% CI) |
||||||
|---|---|---|---|---|---|---|
| Total |
Male |
Female |
||||
| Model 1a | Model 2b | Model 1a | Model 2b | Model 1a | Model 2b | |
| Total | 1.31 (1.30–1.32)c | 1.22 (1.21–1.22)c | 1.36 (1.34–1.37)c | 1.24 (1.23–1.25)c | 1.26 (1.25–1.28)c | 1.18 (1.17–1.20) |
| Oropharyngeal | 1.08 (1.04–1.11)c | 0.97 (0.94–1.00) | 1.16 (1.11–1.22)c | 1.05 (1.00–1.10) | 1.02 (0.98–1.07) | 0.92 (0.88–0.96)d |
| Esophageal | 1.02 (0.95–1.10) | 0.97 (0.90–1.04) | 1.08 (1.00–1.16) | 1.02 (0.95–1.11) | 0.83 (0.70–1.00) | 0.76 (0.64–0.91)d |
| Stomach | 1.16 (1.14. 1.18)c | 1.13 (1.10–1.15)c | 1.15 (1.13–1.18)c | 1.12 (1.10–1.15)c | 1.18 (1.14–1.22)c | 1.14 (1.10–1.18)c |
| Colorectal | 1.28 (1.26–1.31)c | 1.21 (1.18–1.23)c | 1.29 (1.26–1.33)c | 1.21 (1.19–1.24)c | 1.28 (1.24–1.32)c | 1.20 (1.16–1.23)c |
| Liver | 1.73 (1.71–1.76)c | 1.43 (1.41–1.45)c | 1.84 (1.80–1.87)c | 1.49 (1.46–1.51)c | 1.52 (1.48–1.57)c | 1.33 (1.29–1.37)c |
| Pancreatic | 2.12 (2.07–2.18)c | 1.98 (1.93–2.03)c | 2.22 (2.15–2.30)c | 2.06 (1.99–2.13)c | 2.02 (1.94–2.09)c | 1.88 (1.81–1.96)c |
| Laryngeal | 1.25 (1.15–1.35)c | 1.18 (1.08–1.28)c | 1.28 (1.18–1.40)c | 1.21 (1.11–1.32)c | 1.03 (0.80–1.33) | 0.95 (0.73–1.22) |
| Lung | 1.19 (1.16–1.21)c | 1.14 (1.12–1.16)c | 1.21 (1.18–1.24)c | 1.17 (1.15–1.20)c | 1.15 (1.11–1.19)c | 1.08 (1.04–1.11)c |
| Kidney | 1.45 (1.38–1.52)c | 1.24 (1.18–1.30)c | 1.47 (1.39–1.55)c | 1.26 (1.19–1.34)c | 1.42 (1.32–1.53)c | 1.20 (1.11–1.29)c |
| Bladder | 1.37 (1.32–1.43)c | 1.28 (1.23–1.33)c | 1.40 (1.33–1.47)c | 1.30 (1.24–1.37)c | 1.35 (1.25–1.44)c | 1.23 (1.14–1.32)c |
| Leukemia | 1.38 (1.26–1.50)c | 1.29 (1.18–1.42)c | 1.33 (1.18–1.49)c | 1.25 (1.11–1.41)c | 1.46 (1.27–1.67)c | 1.36 (1.18–1.56)c |
| Thyroid | 1.25 (1.22–1.29)c | 1.17 (1.14–1.21)c | 1.47 (1.39–1.55)c | 1.36 (1.28–1.44)c | 1.19 (1.15–1.23)c | 1.12 (1.08–1.16)c |
| Prostate | 1.24 (1.22–1.27)c | 1.12 (1.10–1.14)c | 1.24 (1.22–1.27)c | 1.12 (1.10–1.14)c | - | - |
| Breast | 1.10 (1.05–1.14)c | 1.07 (1.03–1.11)c | - | - | 1.09 (1.05–1.14)c | 1.07 (1.03–1.11)c |
| Cervical | 1.10 (1.03–1.16)c | 1.06 (1.00–1.12) | - | - | 1.09 (1.03–1.16)c | 1.06 (1.00–1.12) |
| Endometrial | 1.41 (1.27–1.55)c | 1.34 (1.21–1.48)c | - | - | 1.41 (1.27–1.55)c | 1.34 (1.21–1.48)c |
| Ovary | 1.05 (0.99–1.12) | 1.03 (0.97–1.09) | - | - | 1.05 (0.99–1.12) | 1.03 (0.97–1.09) |
HR, hazard ratio; CI, confidence interval.
a
Model 1 were adjusted for age and sex.
b
Model 2 were adjusted for age, sex, income, place, hypertension, hyperlipidemia, chronic liver disease, ischemic heart disease, and chronic kidney disease.
c
Significantly increased compared to non-diabetes group (p < 0.05).
d
Significantly decreased compared to non-diabetes group (p < 0.05).